Company Profile
Transgenic develops, distributes, and licenses genetically modified animals and antibodies in Japan. Its business is organized into Drug Discovery Support Business and Investment and Consulting Business segments.
The company provides glycan synthesis and analysis services. Its portfolio also includes non-clinical studies for pharmaceuticals, foods, cosmetics, chemical substances, etc., as well as various safety tests for foods, and pharmaceutical agents, support for bioequivalence test
Including clinical trials, pharmacokinetic measurements, and the preparation of clinical trial reports, and as well as hospital support services drug efficiency and pharmacological test and safety studies.
Its portfolio also includes sugar chain analysis and synthesis services, advice and support services including M&A, business revitalization, business succession services, and contract production services, such as genetically modified mice, antibodies, protein hypers, and expressing cells
Sells mouse-related products and mouse models, and research reagents. Additionally, it offers support service, including business succession and business revitalization, business succession, and investment business consultancy services. Incorporated in 1998 and headquartered in Fukuoka City, Japan, Transgenic was formerly known as Trans Genic Inc. before rebranding in October 2024.